Monique Dodd has been working as a Pharmacist Clinician at TriCore Reference Laboratories since July 2016. She is currently Manager of Enterprise Clinical Solutions for the Diagnostic Optimization team with the Rhodes Group. Her role is to design laboratory-driven targeted interventions to optimize screening, diagnosis, monitoring and treatment of high cost, high risk and high frequency health conditions. Her areas of focus are infectious diseases, chronic pain management/opioid abuse and anticoagulation.
Dr. Dodd has a unique education background which brings laboratory diagnostics and pharmacy together. She earned her Bachelor’s of Science in Medical Laboratory Sciences from the University of New Mexico Health Sciences Center in 2007. She was hired at TriCore as a Medical Technologist working for the Infectious Disease Research and Development team where she worked for three years. She was then accepted to the University of New Mexico College of Pharmacy in 2010 where she interned in the infectious disease lab. Upon graduation in 2014, she entered into a collaborative Post-Graduate Year-One Residency with TriCore and the University of New Mexico College of Pharmacy, with a focus in clinical pharmacy and laboratory diagnostics. Through this existing partnership, she continued her training and earned her Pharmacist Clinician license while completing a Pharmacy Fellowship in 2016 with TriCore.
As a Pharmacist Clinician with the Rhodes Group, Dr. Dodd focuses on designing actionable and real-time targeted intervention for payers, health systems and providers that aim to improve the health of the population.
Post-Graduate Pharmacy Fellowship, TriCore Reference Laboratories (2016)
Post-Graduate Year-One Pharmacy Residency, University of New Mexico College of Pharmacy (2015)
Doctor of Pharmacy, University of New Mexico College of Pharmacy (2014)
Bachelor of Science in Medical Laboratory Sciences, University of New Mexico Health Sciences Center (2007)
New Mexico State Board of Pharmacy: Pharmacist Clinician License
New Mexico State Board of Pharmacy: Pharmacist License
Clinical Assistant Professor University of New Mexico College of Pharmacy
SIDP Antimicrobial Stewardship Certificate
ASCP Board of Certification: Medical Laboratory Scientist Certification Maintenance
Opportunity for Real-Time, Longitudinal Clinical Laboratory Data to Enhance Diabetes Disease Surveillance: A cross-sectional laboratory database-enabled population study
Journal of Applied Laboratory Medicine, 08.28.2020
With the gradual yearly decrease of reimbursement for laboratory services due to the Protecting Access to Medicare Act (PAMA), it has become imperative for clinical laboratories to diversify and find novel methods that highlight their value. This study supports the value proposition of using laboratory data for diabetes surveillance, as well as a tool for future population health interventions. Using clinical laboratory data is an inexpensive method that can be automated and provide real-time longitudinal insights. Therefore, this method can be a timely way to stratify patients at risk, observe diabetes patterns, and aid public health officials to build more focused targeted interventions.
Beyond Test Results: Defining the Role of Clinical Laboratories in Value-Based Population Health Equity
AACC.org Clinical Laboratory News, 03.01.2020
Clinical laboratories figure prominently in the continuum of care by delivering timely and accurate results to clinicians. As the U.S. healthcare system evolves into a value-based care model, laboratories are moving from transactional interactions to approaches that support integrated services and proactive population health. This means they are actively evaluating the strength of their data and capitalizing on their domain knowledge to develop actionable insights from longitudinal trends within the data.
Improving the Delivery of Healthcare Through Clinical Diagnostic Insights:
A valuation of laboratory medicine through "Clinical Lab 2.0."
Journal of Applied Laboratory Medicine, 10.23.2019
Laboratory medicine is able to provide meaningful clinical diagnostic insights for population health initiatives that result in improved short- and long-term patient outcomes and drive cost-effective care. Opportunities include data analysis with longitudinal laboratory data, identification of patient-specific targeted interventions, and development of clinical decision support tools. Laboratories will need to leverage the skills and knowledge of their multidisciplinary staff, along with their extensive patient data sets, through innovative analytics to meet these objectives.
Prescription for Disruption: Including a PHarmacist as Part of the Clinical Laboratory Team
Clinical Microbiology Newsletter, 12.15.2018
Hiring pharmacists to work in the clinical laboratory is a novel and confounding disruption to the common practice of pharmacy and clinical laboratory. Bringing the these two health professions together helps promote the clinical laboratory as an integral health care partner rather than a commodity in the optimization of patient care. Additionally, training pharmacists in the complexities of laboratory medicine enhances their understanding of diagnostic and clinical inefficiencies and creates opportunities to improve the continuum of care. As health care transforms from an unsustainable fee-for-service business model to a value-based patient-centered care model, the pharmacist-laboratorian partnership focuses on creating clinical decision support initiatives that impact health care for the patient and the population. The purpose of this article is to describe the rational for clinical solutions pharmacists in the clinical laboratory and their role in improving community-wide antimicrobial stewardship by capitalizing on the collaboration between pharmacist and laboratorian.
Measuring What Matters: How the Laboratory Contributes Value in the Opioid Crisis
Journal of Applied Laboratory Medicine, 11.01.2020
With over 20 years of the opioid crisis, our collective response has evolved to address the ongoing needs related to the management of opioid use and opioid use disorder. There has been an increasing recognition of the need for standardized metrics to evaluate organizational management and stewardship. The clinical laboratory, with a wealth of objective and quantitative health information, is uniquely poised to support opioid stewardship and drive valuable metrics for opioid prescribing practices and opioid use disorder (OUD) management. To identify laboratory-related insights that support these patient populations, a collection of 5 independent institutions, under the umbrella of the Clinical Laboratory 2.0 movement, developed and prioritized metrics.